XML 130 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Basis of Presentation and Significant Accounting Policies (Details Narrative) - USD ($)
6 Months Ended
Aug. 21, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Product Information [Line Items]        
Common stock, par value       $ 0.02
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer Two [Member]        
Product Information [Line Items]        
Concentration Risk, Percentage   45.00% 45.00%  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer Two [Member]        
Product Information [Line Items]        
Concentration Risk, Percentage   75.00% 53.00%  
HWH Korea [Member]        
Product Information [Line Items]        
Shares issued under the term of share exchange   127,179,000    
Periodic fee remittance percentage   2.50%    
Due from Related Parties   $ 286,000   $ 1,100,000
Remitted amount, net of fees and other expenses   253,000    
HWH Korea [Member] | Other Current Liabilities [Member]        
Product Information [Line Items]        
Due from Related Parties   $ 315,000    
Impact BioMedical, Inc. [Member] | Share Exchange Agreement [Member]        
Product Information [Line Items]        
Shares issued under the term of share exchange 483,334      
Common stock, par value $ 0.02      
Shares Issued, Price Per Share 6.48      
Impact BioMedical, Inc. [Member] | Share Exchange Agreement [Member] | Series A Preferred Stock [Member]        
Product Information [Line Items]        
Shares Issued, Price Per Share $ 1,000      
Number of newly issued shares 46,868